Cyclophosphamide
I 77218
Phase 2 small_molecule terminated
Quick answer
Cyclophosphamide for Metastatic Bladder Urothelial Carcinoma is a Phase 2 program (small_molecule) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IOVANCE BIOTHERAPEUTICS, INC.
- Indication
- Metastatic Bladder Urothelial Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated